An ESPGHAN Position Paper on the Use of Low-FODMAP Diet in Pediatric Gastroenterology.
Journal
Journal of pediatric gastroenterology and nutrition
ISSN: 1536-4801
Titre abrégé: J Pediatr Gastroenterol Nutr
Pays: United States
ID NLM: 8211545
Informations de publication
Date de publication:
01 09 2022
01 09 2022
Historique:
pubmed:
17
6
2022
medline:
24
8
2022
entrez:
16
6
2022
Statut:
ppublish
Résumé
Excluding oligo-, di-, monosaccharides and polyols (FODMAPs) from the diet is increasingly being used to treat children with gastrointestinal complaints. The aim of this position paper is to review the available evidence on the safety and efficacy of its use in children and provide expert guidance regarding practical aspects in case its use is considered . Members of the Gastroenterology Committee, the Nutrition Committee and the Allied Health Professionals Committee of the European Society for Pediatric Gastroenterology Hepatology and Nutrition contributed to this position paper. Clinical questions regarding initiation, introduction, duration, weaning, monitoring, professional guidance, safety and risks of the diet are addressed. A systematic literature search was performed from 2005 to May 2021 using PubMed, MEDLINE and Cochrane Database of Systematic Reviews. In the absence of evidence, recommendations reflect the expert opinion of the authors. The systematic literature search revealed that the low-FODMAP diet has not been comprehensively studied in children. Indications and contraindications of the use of the diet in different pediatric gastroenterological conditions are discussed and practical recommendations are formulated. There is scarce evidence to support the use of a low-FODMAP diet in children with Irritable Bowel Syndrome and no evidence to recommend its use in other gastrointestinal diseases and complaints in children. Awareness of how and when to use the diet is crucial, as a restrictive diet may impact nutritional adequacy and/or promote distorted eating in vulnerable subjects. The present article provides practical safety tips to be applied when the low-FODMAP diet is considered in children.
Identifiants
pubmed: 35706093
doi: 10.1097/MPG.0000000000003526
pii: 00005176-202209000-00028
doi:
Substances chimiques
Disaccharides
0
Monosaccharides
0
Oligosaccharides
0
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
356-368Informations de copyright
Copyright © 2022 by European Society for European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.
Déclaration de conflit d'intérêts
The authors report no conflicts of Interest.
Références
Gibson PR, Shepherd SJ. Personal view: food for thought—Western lifestyle and susceptibility to Crohn’s disease. The FODMAP hypothesis. Aliment Pharmacol Ther 2005;21:1399–409.
Whelan K, Martin LD, Staudacher HM, et al. The low FODMAP diet in the management of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintroduction and personalisation inclinical practice. J Hum Nutr Diet 2018;31:239–55.
Hill P, Muir JG, Gibson PR. Controversies and recent developments of the low-FODMAP diet. Gastroenterol Hepatol (N Y) 2017;13:36–45.
van Lanen AS, de Bree A, Greyling A. Efficacy of a low-FODMAP diet in adult irritable bowel syndrome: asystematic review and meta-analysis. Eur J Nutr 2021;60:3505–22.
Ford AC, Moayyedi P, Chey WD, et al. American college of gastroenterology on management of irritable bowel syndrome. Am J Gastroenterol 2018;113(Suppl 2):1–18.
McKenzie YA, Bowyer RK, Leach H, et al. British dietetic association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update). J Hum Nutr Diet 2016;29:549–75.
Staudacher HM, Ralph FSE, Irving PM, et al. Nutrient intake, diet quality, and diet diversity in irritable bowel syndrome and the impact of the low FODMAP diet. J Acad Nutr Diet 2020;120:535–47.
Dogan G, Yavuz S, Aslantas H, et al. Is low FODMAP diet effective in children with irritable bowel syndrome? North Clin Istanb 2020;7:433–7.
Nogay NH, Walton J, Roberts KM, et al. The effect of the low FODMAP diet on gastrointestinal symptoms, behavioral problems and nutrient intake in children with autism spectrum disorder: a randomized controlled pilot trial. J Autism Dev Disord 2021;51:2800–11.
Boradyn KM, Jarocka-Cyrta E, Przybylowicz KE, et al. Parental opinion about the low diet in dietary treatment of children with functional abdominal pain. Int J Environ Res Public Health 2020;17:5554.
Chumpitazi BP, Cope JL, Hollister EB, et al. Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Aliment Pharmacol Ther 2015;42:418–27.
Cyrkot S, Marcon M, Brill H, et al. FODMAP intake in children with coeliac disease influences diet quality and health-related quality of life and has no impact on gastrointestinal symptoms. Int J Food Sci Nutr 2021;72:1–12.
Baranguán Castro ML, Ros Arnal I, et al. [Implementation of a low FODMAP diet for functional abdominal pain]. An Pediatr (Barc) 2019;90:180–6.
Chumpitazi BP, Hollister EB, Oezguen N, et al. Gut microbiota influences low fermentable substrate diet efficacy in children with irritable bowel syndrome. Gut Microbes 2014;5:165–75.
Hyams JS, Di Lorenzo C, Saps M, et al. Functional disorders: children and adolescents. Gastroenterology 2016:S0016-5085(16)00181-5.
Murray K, Wilkinson-Smith V, Hoad C, et al. Differential effects of FODMAPs (fermentable oligo-, di-, mono-saccharides and polyols) on small and large intestinal contents in healthy subjects shown by MRI. Am J Gastroenterol 2014;109:110–9.
El-Salhy M, Gundersen D. Diet in irritable bowel syndrome. Nutr J 2015;14:36.
Chumpitazi BP, Shulman RJ. Dietary carbohydrates and childhood functional abdominal pain. Ann Nutr Metab 2016;68(Suppl 1):8–17.
Iacovou M. Adapting the low FODMAP diet to special populations: infants and children. J Gastroenterol Hepatol 2017;32(Suppl 1):43–5.
Iacovou M, Craig SS, Yelland GW, et al. Randomised clinical trial: reducing the intake of dietary FODMAPs of breastfeeding mothers is associated with a greater improvement of the symptoms of infantile colic than for a typical diet. Aliment Pharmacol Ther 2018;48:1061–73.
Mumolo MG, Rettura F, Melissari S, et al. Is gluten the only culprit for non-celiac gluten/wheat sensitivity? Nutrients 2020;12:3785.
Dieterich W, Schuppan D, Schink M, et al. Influence of low FODMAP and gluten-free diets on disease activity and intestinal microbiota in patients with non-celiac gluten sensitivity. Clin Nutr 2019;38:697–707.
Biesiekierski JR, Peters SL, Newnham ED, et al. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology 2013;145:320–8.e1.
Skodje GI, Sarna VK, Minelle IH, et al. Fructan, rather than gluten, induces symptoms in patients with self-reported non-celiac gluten sensitivity. Gastroenterology 2018;154:529–539.e2.
Ruemmele FM. Non-Celiac gluten sensitivity: a challenging diagnosis in children with abdominal pain. Ann Nutr Metab 2018;73(Suppl 4):39–46.
Pedersen N, Ankersen DV, Felding M, et al. Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease. World J Gastroenterol 2017;23:3356–66.
Cox SR, Lindsay JO, Fromentin S, et al. Effects of low FODMAP diet on symptoms, fecal microbiome, and markers of inflammation in patients with quiescent inflammatory bowel disease in a randomized trial. Gastroenterology 2020;158:176–188.e7.
Zhan YL, Zhan YA, Dai SX. Is a low FODMAP diet beneficial for patients with inflammatory bowel disease? A meta-analysis and systematic review. Clin Nutr 2018;37:123–9.
Bohm M, Siwiec RM, Wo JM. Diagnosis and management of small intestinal bacterial overgrowth. Nutr Clin Pract 2013;28:289–99.
Korterink JJ, Benninga MA, van Wering HM, et al. Glucose hydrogen breath test for small intestinal bacterial overgrowth in children with abdominal pain-related functional gastrointestinal disorders. J Pediatr Gastroenterol Nutr 2015;60:498–502.
Scarpellini E, Giorgio V, Gabrielli M, et al. Prevalence of small intestinal bacterial overgrowth in children with irritable bowel syndrome: a case-control study. J Pediatr 2009;155:416–20.
Collins BS, Lin HC. Chronic abdominal pain in children is associated with high prevalence of abnormal microbial fermentation. Dig Dis Sci 2010;55:124–30.
Gibson PR, Shepherd SJ. Food choice as a key management strategy for functional gastrointestinal symptoms. Am J Gastroenterol 2012;107(5):657–66; quiz 67.
Staudacher HM, Whelan K, Irving PM, et al. Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J Hum Nutr Diet 2011;24:487–95.
Avelar Rodriguez D, Ryan PM, Toro Monjaraz EM, et al. Small intestinal bacterial overgrowth in children: a state-of-the-art review. Front Pediatr 2019;7:363.
Rajilić-Stojanović M, Biagi E, Heilig HG, et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 2011;141:1792–801.
Jeffery IB, O’Toole PW, Öhman L, et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut 2012;61:997–1006.
Naseri K, Dabiri H, Rostami-Nejad M, et al. Influence of low FODMAP-gluten free diet on gut microbiota alterations and symptom severity in Iranian patients with irritable bowel syndrome. BMC Gastroenterol 2021;21:292.
Staudacher HM, Lomer MC, Anderson JL, et al. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr 2012;142:1510–8.
Staudacher HM, Lomer MCE, Farquharson FM, et al. A diet low in fodmaps reduces symptoms in patients with irritable bowel syndrome and a probiotic restores bifidobacterium species: a randomized controlled trial. Gastroenterology 2017;153:936–47.
Halmos EP, Christophersen CT, Bird AR, et al. Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Gut 2015;64:93–100.
Bennet SMP, Böhn L, Störsrud S, et al. Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs. Gut 2018;67:872–81.
McIntosh K, Reed DE, Schneider T, et al. FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial. Gut 2017;66:1241–51.
Staudacher HM, Rossi M, Kaminski T, et al. Long-term personalized low FODMAP diet improves symptoms and maintains luminal Bifidobacteria abundance in irritable bowel syndrome. Neurogastroenterol Motil 2022;34:e14241.
Zhang Y, Feng L, Wang X, et al. Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet compared with traditional dietary advice for diarrhea-predominant irritable bowel syndrome: a parallel-group, randomized controlled trial with analysis of clinical and microbiological factors associated with patient outcomes. Am J Clin Nutr 2021;113:1531–45.
Eetemadi A, Tagkopoulos I. Methane and fatty acid metabolism pathways are predictive of Low-FODMAP diet efficacy for patients with irritable bowel syndrome. Clin Nutr 2021;40:4414–21.
Valdez-Palomares F, Nambo-Venegas R, Uribe-García J, et al. Intestinal microbiota fingerprint in subjects with irritable bowel syndrome responders to a low FODMAP diet. Food Funct 2021;12:3206–18.
Chumpitazi BP, Hoffman KL, Smith DP, et al. Fructan-sensitive children with irritable bowel syndrome have distinct gut microbiome signatures. Aliment Pharmacol Ther 2021;53:499–509.
Halmos EP. Editorial: defining a microbial signature to predict non-response to a FODMAP diet-a step closer or is it? Aliment Pharmacol Ther 2021;53:646–7.
Gröber U, Reichrath J, Holick MF. Live longer with vitamin D? Nutrients 2015;7:1871–80.
O’Keeffe M, Jansen C, Martin L, et al. Long-term impact of the low-FODMAP diet on gastrointestinal symptoms, dietary intake, patient acceptability, and healthcare utilization in irritable bowel syndrome. Neurogastroenterol Motil 2018;30:1–13.
Eswaran S, Dolan RD, Ball SC, et al. The impact of a 4-week low-FODMAP and mNICE diet on nutrient intake in a sample of US adults with irritable bowel syndrome with diarrhea. J Acad Nutr Diet 2020;120:641–9.
Eswaran SL, Chey WD, Han-Markey T, et al. A randomized controlled trial comparing the low FODMAP diet vs. modified NICE guidelines in US adults with IBS-D. Am J Gastroenterol 2016;111:1824–32.
Böhn L, Störsrud S, Liljebo T, et al. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial. Gastroenterology 2015;149:1399–407.e2.
Satherley R, Howard R, Higgs S. Disordered eating practices in gastrointestinal disorders. Appetite 2015;84:240–50.
Mari A, Hosadurg D, Martin L, et al. Adherence with a low-FODMAP diet in irritable bowel syndrome: are eating disorders the missing link? Eur J Gastroenterol Hepatol 2019;31:178–82.
Chumpitazi BP, Alfaro-Cruz L, Zia JK, et al. Commentary: adherence with a low-FODMAP diet in irritable bowel syndrome: are eating disorders the missing link? Front Nutr 2019;6:136.
Larson N, Neumark-Sztainer D, Laska MN, et al. Young adults and eating away from home: associations with dietary intake patterns and weight status differ by choice of restaurant. J Am Diet Assoc 2011;111:1696–703.
Scarlata K, Catsos P, Smith J. From a dietitian’s perspective, diets for irritable bowel syndrome are not one size fits all. Clin Gastroenterol Hepatol 2020;18:543–5.
Varni JW, Kay MT, Limbers CA, et al. PedsQL gastrointestinal symptoms module item development: qualitative methods. J Pediatr Gastroenterol Nutr 2012;54:664–71.
Alfaro-Cruz L, Heitkemper M, Chumpitazi BP, et al. Literature review: dietary intervention adherence and adherence barriers in functional gastrointestinal disorder studies. J Clin Gastroenterol 2020;54:203–11.
Pensabene L, Salvatore S, Turco R, et al. Low FODMAPs diet for functional abdominal pain disorders in children: critical review of current knowledge. J Pediatr (Rio J) 2019;95:642–56.
Lacy BE, Pimentel M, Brenner DM, et al. ACG Clinical guideline: management of irritable bowel syndrome. Am J Gastroenterol 2021;116:17–44.
Dionne J, Ford AC, Yuan Y, et al. A systematic review and meta-analysis evaluating the efficacy of a gluten-free diet and a low fodmaps diet in treating symptoms of irritable bowel syndrome. Am J Gastroenterol 2018;113:1290–300.
Krogsgaard LR, Lyngesen M, Bytzer P. Systematic review: quality of trials on the symptomatic effects of the low FODMAP diet for irritable bowel syndrome. Aliment Pharmacol Ther 2017;45:1506–13.
Barrett JS. How to institute the low-FODMAP diet. J Gastroenterol Hepatol 2017;32(Suppl 1):8–10.
Peters SL, Yao CK, Philpott H, et al. Randomised clinical trial: the efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2016;44:447–59.
Tuck C, Barrett J. Re-challenging FODMAPs: the low FODMAP diet phase two. J Gastroenterol Hepatol 2017;32(Suppl 1):11–5.
Stróżyk A, Horvath A, Muir J, et al. Effect of a low-FODMAP diet for the management of functional abdominal pain disorders in children: a study protocol for a randomized controlled trial. Nutr J 2021;20:1.
Gupta S, Schaffer G, Saps M. Pediatric irritable bowel syndrome and other functional abdominal pain disorders: an update of non-pharmacological treatments. Expert Rev Gastroenterol Hepatol 2018;12:447–56.
Joc EB, Madro A, Celinski K, et al. Quality of life of patients with irritable bowel syndrome before and after education. Psychiatr Pol 2015;49:821–33.
Mishima Y, Furuta K, Ishihara S, et al. [Education to the patients of irritable bowel syndrome: diet and lifestyle advice]. Nihon Rinsho 2006;64:1511–5.
Ostgaard H, Hausken T, Gundersen D, et al. Diet and effects of diet management on quality of life and symptoms in patients with irritable bowel syndrome. Mol Med Rep 2012;5:1382–90.
Alfaro Cruz L, Minard C, Guffey D, et al. Does a minority of children with functional gastrointestinal disorders receive formal diet advice? JPEN J Parenter Enteral Nutr 2020;44:1525–9.
Reed-Knight B, Squires M, Chitkara DK, et al. Adolescents with irritable bowel syndrome report increased eating-associated symptoms, changes in dietary composition, and altered eating behaviors: a pilot comparison study to healthy adolescents. Neurogastroenterol Motil 2016;28:1915–20.
Alfaro-Cruz L, Kaul I, Zhang Y, et al. Assessment of quality and readability of internet dietary information on irritable bowel syndrome. Clin Gastroenterol Hepatol 2019;17:566–7.
O’Keeffe M, Lomer MC. Who should deliver the low FODMAP diet and what educational methods are optimal: a review. J Gastroenterol Hepatol 2017;32:23–6.
Ankersen DV, Carlsen K, Marker D, et al. Using eHealth strategies in delivering dietary and other therapies in patients with irritable bowel syndrome and inflammatory bowel disease. J Gastroenterol Hepatol 2017;32(Suppl 1):27–31.
Fodor I, Man SC, Dumitrascu DL. Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet in children. World J Clin Cases 2019;7:2666–74.
Chen J, Gemming L, Hanning R, et al. Smartphone apps and the nutrition care process: current perspectives and future considerations. Patient Educ Couns 2018;101:750–7.
Pourmand H, Esmaillzadeh A. Consumption of a low fermentable oligo-, di-, mono-saccharides, and polyols diet and irritable bowel syndrome: a systematic review. Int J Prev Med 2017;8:104.
Chumpitazi BP, Lim J, McMeans AR, et al. Evaluation of FODMAP carbohydrates content in selected foods in the United States. J Pediatr 2018;199:252–5.